Companies
The 7 companies we follow, with their active clinical studies and the next expected milestone.
| Company | Ticker | Active studies | Latest phase | Next primary completion |
|---|---|---|---|---|
| Beam Therapeutics | BEAM | 8 | Phase 1/2 | Dec 2026 |
| CRISPR Therapeutics | CRSP | 11 | Phase 3 | 6 Jun 2027 |
| Cereno Scientific AB | CRNO-B.ST | 1 | Phase 2 | 2 Feb 2029 |
| Circio Holding ASA | CRNA.OL | 3 | Phase 2 | 19 May 2027 |
| Intellia Therapeutics | NTLA | 7 | Phase 3 | Jul 2027 |
| Moderna | MRNA | 1 | Phase 1/2 | – |
| Vertex Pharmaceuticals | VRTX | 16 | Phase 4 | 9 Jun 2027 |
We add companies gradually. Each new company is checked against its registered studies before it is listed.